Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series

Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series

Background: National treatment guidelines recommend glucagon-like peptide receptor agonists (GLP-1 RAs) as add-on therapy to oral agents. However, GLP-1 RAs in combination with dipeptidyl peptidase-4 (DPP-4) inhibitors is not recommended due to a lack of evidence. Objective: This case series aims t...

Full description

Bibliographic Details
Main Authors: Lajthia E, Bucheit JD, Nadpara PA, Dixon DL, Caldas LM, Murchie M, Sisson EM
Format: Article
Language:English
Published: Centro de Investigaciones y Publicaciones Farmaceuticas 2019-12-01
Series:Pharmacy Practice
Subjects:
diabetes mellitus type 2
drug combinations
glucagon-like peptide 1
dipeptidyl-peptidase iv inhibitors
hypoglycemic agents
blood glucose
body weight
retrospective studies
united states
Online Access:https://pharmacypractice.org/journal/index.php/pp/article/view/1588

Internet

https://pharmacypractice.org/journal/index.php/pp/article/view/1588

Similar Items